Aspirin-Exacerbated Respiratory Diseaseis a syndrome characterized by asthma, chronic rhinosinusitis with nasal polyposis, and hypersensitivity to aspirin and cyclooxygenase-1 inhibitors. Aspirin-Exacerbated Respiratory Disease is present in 7.2% of patients with asthma and it´s prevalence increases in severe asthma. Currently there are no specific markers and an aspirin challenge test is required to confirm the diagnosis. Current standard treatment is aspirin desensitization followed by high-dose aspirin. Here is a brief review of Aspirin-Exacerbated Respiratory Disease and it´s treatment.
Paper No:
4291
